Surgical Oncology

Medicine & Life Sciences

1. Adenocarcinoma 63%
2. Appendiceal Neoplasms 8%
3. Biomarkers 7%
4. Biopsy 7%
5. Breast 20%
6. Breast Neoplasms 16%
7. Carcinogenesis 6%
8. Carcinoma 15%
9. Catheters 6%
10. Cell Movement 6%
11. Colonic Neoplasms 11%
12. Colorectal Neoplasms 21%
13. Confidence Intervals 6%
14. Curriculum 16%
15. Cytoreduction Surgical Procedures 19%
16. Databases 10%
17. Dexamethasone 6%
18. Drug Therapy 14%
19. Esophageal Neoplasms 11%
20. Esophagectomy 7%
21. Esophagogastric Junction 10%
22. Fluorescence 10%
23. Gallbladder Neoplasms 11%
24. gemcitabine 19%
25. Genome 23%
26. Geranyltranstransferase 5%
27. Granulosa Cell Tumor 7%
28. Growth 10%
29. Guidelines 34%
30. Hepatectomy 6%
31. Hepatocellular Carcinoma 7%
32. Incidence 9%
33. India 9%
34. Indocyanine Green 6%
35. Induced Hyperthermia 15%
36. Internship and Residency 16%
37. Kidney Pelvis 6%
38. Laparoscopy 6%
39. Length of Stay 7%
40. Liver 22%
41. Liver Neoplasms 7%
42. Lymph Nodes 8%
43. Margins of Excision 10%
44. Medical Students 9%
45. Melanoma 6%
46. Meta-Analysis 7%
47. Morbidity 9%
48. Mortality 17%
49. Mucins 11%
50. Mutation 15%
51. Nanoparticles 7%
52. Neoadjuvant Therapy 17%
53. Neoplasm Metastasis 42%
54. Neoplasms 88%
55. Neoplastic Stem Cells 6%
56. Neuroendocrine Tumors 10%
57. Nomograms 9%
58. Odds Ratio 6%
59. Oncologists 40%
60. Ovarian Neoplasms 10%
61. Palliative Care 12%
62. Pancreas 13%
63. Pancreatectomy 16%
64. Pancreatic Ducts 11%
65. Pancreatic Fistula 7%
66. Pancreatic Neoplasms 100%
67. Pancreaticoduodenectomy 21%
68. Pancreatitis 6%
69. Pandemics 5%
70. Pathologists 15%
71. Pathology 7%
72. Peritoneal Diseases 23%
73. Peritoneal Neoplasms 40%
74. Pharmacists 10%
75. Physicians 9%
76. Practice Guidelines 16%
77. Primary Hyperparathyroidism 6%
78. Prodrugs 11%
79. Prostate 8%
80. Prostatic Neoplasms 9%
81. Proteins 7%
82. Pseudomyxoma Peritonei 7%
83. Radiologists 12%
84. Radiotherapy 8%
85. Recurrence 10%
86. Segmental Mastectomy 6%
87. Squamous Cell Carcinoma 7%
88. Stomach 6%
89. Stomach Neoplasms 10%
90. Students 6%
91. Surgeons 26%
92. Surgical Oncology 26%
93. Survival 27%
94. Therapeutics 22%
95. Thyroid Neoplasms 8%
96. Thyroidectomy 6%
97. Trefoil Factor-2 6%
98. Urinary Bladder 6%
99. Urinary Bladder Neoplasms 10%
100. Whole Genome Sequencing 6%